Association of immunological changes with clinical efficacy in atopic eczema patients treated with traditional chinese herbal therapy (Zemaphyte®)

International Archives of Allergy and Immunology

Volumn 109, Issue 3, 1996, Pages 243-249

  Latchman, Y ^a   Banerjee, P ^b   Poulter, L W ^b   Rustin, M ^b   Brostoff, J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Atopic eczema; CD23; Immunoglobulin E; Interleukin 2 receptor; Traditional Chinese herbs (Zemaphyte reg; ); Vascular cellular adhesion molecule

Indexed keywords

CD23 ANTIGEN; CHINESE DRUG; IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; ZEMAPHYTE;

ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE CULTURE; MALE; MONONUCLEAR CELL; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TRADITIONAL MEDICINE;

EID: 0030019956     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237245     Document Type: Article

References (39)

1. Morrison JGL. Schulz EJ: Treatmenl of eczema with cyclophosphamide and azathioprine. Br J Dermatol 1978;98:203-207.
2. Morison WI, Parish JA, Fitzpatrick TB: Oral photochemotherapy of atopic eczema. Br J Dermatol 1978;98:25-31.
3. 2. Proc Natl Acad Sci USA 1988:85:6880-6884.
4. Boguniewicz M. Jaffe HS. Izu A. Sullivan M, York D, Geha RS. Leung DYM: Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE. Am J Med 1990:88:365-370.
5. Hanifin JM. Schneider LC, Leung DYM, Ellis C, Jaffe H, Izu A. Bucalo L, Hirabayashi S, Tofte S, Cantu-Gonzales G. Milgrom H, Boguniewicz M. Cooper K: Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993;28:189-197.
6. Rcinhold U, Kukcl S, Brzoska J, Krcyscl H: Systemic interferon gamma treatment in severe atopic dermatitis. J Am Acad Dermatol 1993; 29:58-63.
7. Pung Y, Vetro S, Bellanti J: Use of interferons in atopic (IgE-mediated) disease. Ann Allergy 1993:71:234-238.
8. Reinhold U, Kukel S, Goeden B, Neumann U, Kreysel HW: Functional characterization of skin-infiltrating lymphocytes in atopic dermatitis. Clin Exp Immunol 1991;86:444-448.
9. Sowden JM. Powell RJ. Allen BR: Selective activation of circulating CD4+ lymphocytes in severe adult atopic dematitis. BrJ Dermatol 1992; 127:228-232.
10. Van der Heiijdcn FL, Wierenga EA, Bos JD, Kapsenberg ML: High frequency of IL4 producing CD4+ allergen specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991;97:389-394.
11. Ramb-Lindhauser C, Feldmann A, Rotte M: Characterization of grass pollen reactive T cell line derived from lesional skin. Arch Dermatol Res 1991;283:71-76.
12. Grewe M, Gyutko K, Schopf, Krutmann J: Lesional expression of intcrferon-y in atopic eczema. Lancet 1994;343:25-26.
13. Rao A: NF-ATp: A transcription factor required for the co-ordinate induction of several cytokine genes. Immunol Today 1994;15:274-281.
14. Sowden JM, Berh-Jones J, Ross JD, Motley RJ, Marks R, Finlay AY, Salck MS, Graham-Brown RA, Allen BR, Camp RD: Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991;338:137-140.
15. Joost T, Heule F, Korstanie M, Van den Broek, Stanveld H, Vloten W: Cyclosporin in atopic dermatitis: A multicentre placebo-controlled study. BrJ Dermatol 1994;130:634-640.
16. Granuland H, Erkko P. Sinisalo M, Reitamo S: Cyclosporin in atopic dermatitis: Time to lapse and effect of intermittent therapy. BrJ Dermatol 1995;132:106-112.
17. Sheehan MP. Atherton DJ: A controlled trial of traditional Chinese medicinal plants in widespread non-exudative eczema. Br J Dermatol 1992;126:483-488.
18. Sheehan MP. Rustin MHA, Atherton DJ. Buckley C. Harris DJ, Brostoff J. Ostlcrc L. Dawson A: A double-blind placebo-controlled study of traditional Chinese herbal therapy in the treatment of adult atopic dermatitis. Lancet 1992; 340:13-17.
19. Sheehan MP. Atherton DJ: One year follow-up of ch ldren treated with Chinese medicinal herbs for atopic eczema. Br J Dermatol 1994; 130:488-493.
20. Jakob T, Hudpith B. Latchman Y, Rycroft R, Brostoff J: Depressed lymphocyte transformation and the role of prostaglandins in atopic dermatitis. Clin Exp Immunol 1990;79:380-384.
21. Banerjcc P. Rustin MHA: Efficacy of a new palatable formulation of Chinese herbal therapy as a treatment of atopic eczema. Br J Dermatol 1994; 131 (suppl 44):26.
22. Colver G, Symons J, Duff G: Soluble interleukin 2 receptor in atopic eczema. Br Med J 1989; 298:1426-1428.
23. Wellicome SM. Kapahi P. Mason J. Lebranchu Y. Yarwood H. Haskard D: Detection of a circulating form of vascular cell adhesion molecule 1: Raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol 1993:92:412-418.
24. Marone G. Casolaro V. Paganclli R. Quinti I: IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells. J Invest Dermatol 1989;93:246-251.
25. Johansson SGO, Juhlin L: Immunoglobulin E in healed atopic dermatitis and after treatment with corticosteroids and azathioprine. Br J Dermatol 1970;82:10-13.
26. Weindel Nielson B, Reimert C, Hammer R, Schiotz PO, Thestrup-Redersen K: Interferon therapy for atopic dermatitis reduces basophil histamine release, but does not reduce scrum IgE or eosinophilic proteins. Allergy 1994:49: 120-128.
27. Melewiez FM, Zeiger RS, Mellon MH, O'Connor RD, Spiegelberg HL: Increased peripheral blood monocytes with Fc receptors for IgE in patients with severe allergic disorders. J Immunol 1981:126:1592-1595.
28. Nakamura K, Okubo Y, Minami M. Furue M, Ishibashi Y: Phenotypic analysis of CD23+ peripheral blood mononuclear cells in atopic dermatitis. BrJ Dermatol 1991;125:543-547.
29. Buckley C, Ivison C, Poulter LW, Rustin MH: FcRf 11/CD23 receptor distribution in patch test reactions to aeroallergens in atopic dermatitis. J Invest Dermatol 1992;99:184-188.
30. Polla BS, Ezckowitz RA, Leung DYM: Monocytes from patients with atopic dermatitis are primed for Superoxide production. J Allergy Clin Immunol 1992:89:545-551.
31. Mossalayi M, Paul-Eugene N, Quaaz F, Arock M, Kolb J, Kilcheer E, Debre P. Dugas B: Involvement of FceRII/CD23 and L-arginine dependent pathway in IgE-mediated stimulation of human monocyte functions. Int Immunol 1994;6:931-934.
32. Latchman Y. Bungy A, Atherton DJ, Rustin M. Brostoff J: Efficacy of traditional Chinese herbal therapy (TCHT) in vitro. A model system for atopic eczema: Inhibition of CD23 expression on blood monocytes, BrJ Dermatol 1995:132: 592-598.
33. Rubin La, Jay G, Nelson DL: The released interleukin 2 receptor binds interleukin 2 efficiently. J Immunol 1986;137:3841-3844.
34. Wuthrich B, Joller-Jemelka H, Helfenstein H, Grob PJ: Levels of soluble interleukin 2 receptors correlate with the severity of atopic dermatitis. Dermatologica 1990; 181:92-97.
35. Sehlcimer RP, Sterbinsky SA, Kaiser J. Bickel C, Klunk D. Tomioka K, Newman W. Luscins-kas F. Gimbrone M, McIntyre B, Boehner B: IL4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: Association with expression of VCAM-1. J Immunol 1992;148:1086-1092.
36. Kojima T. Ono A, Aoki T. Kamcda-Hayashi N, Kobayashi Y: Circulating ICAM-I levels in children with atopic dermatitis. Ann Allergy 1994;73:351-355.
37. Wuthrich B, Joller-Jemelka H: Kagi MK: Levels of soluble ICAM-1 in atopic dermatitis: A new marker for monitoring the clinical activity. Allergy 1995:50:88-89.
38. Rossiter H, van Reijsen F, Mudde G. Bruijn-zeel-Koomen CA. Picker LJ. Kupper TS: Skin disease-related T cells bind to endothelial sclec-tins: Expression of cutaneous lymphocyte antigen (CLA) predicts E selectin but not P-selectin binding. Eur J Immunol 1994;24:205-210.
39. Santamaria Babi LF. Picker LJ, Perez Solcr MT. Drzimalla K, Flohr P. Blaser K, Hauser C: Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med 1995; 181:1935-1940.